Health economics of osteoporosis

Area of Science:

• Health Economics
• Osteoporosis Research
• Clinical Decision Making

Background:

• Cost-effectiveness analysis (CEA) is crucial for healthcare resource allocation in osteoporosis management.
• Existing CEA studies in osteoporosis often lack comprehensive data, limiting their applicability and accuracy.
• International variations in fracture costs and health state consequences are not well-documented.

Purpose of the Study:

• To outline the core principles of cost-effectiveness analysis in the context of osteoporosis.
• To identify critical knowledge gaps hindering robust CEA in osteoporosis.
• To discuss recent advancements and future directions for improving osteoporosis CEA.

Main Methods:

• This paper provides a conceptual review, synthesizing principles of CEA and identifying research needs.
• It examines the limitations of current osteoporosis CEA models.
• It highlights emerging methodologies and data requirements for enhanced analyses.

Main Results:

• Significant gaps exist in understanding the full economic burden of osteoporotic fractures and their impact on health states, especially globally.
• Incorporating patient adherence to treatment into economic models is a key development.
• The FRAX tool offers a pathway to assess cost-effectiveness across diverse patient risk profiles.

Conclusions:

• More comprehensive international data on fracture costs and health outcomes are essential for accurate osteoporosis CEA.
• Adherence and individualized risk assessment using tools like FRAX are vital for advancing cost-effectiveness modeling.
• Establishing intervention thresholds based on CEA principles will optimize resource allocation for osteoporosis prevention and treatment.